# how close are we to the nebius limit?

- **Started:** 2026-10-31 15:06 EDT (UTC-4) through 2026-11-01 02:00, then EST (UTC-5)
- **Last activity:** 2026-10-31 18:45 EDT (UTC-4) through 2026-11-01 02:00, then EST (UTC-5)
- **User messages:** 3
- **Subagents:** 0
- **Transcript ID:** `b847b2a8-57bb-44d4-a712-f83e3bb22cda`

## Conversation

### 2026-10-31 15:06 — Turn 1 (User)

> how close are we to the nebius limit?

**Assistant:**

I should search the repo to figure out what "nebius limit" is referring to.

I should search further for the specific limit details, looking into the nebius context and the nebius_mcp.py file.

The repo doesn't record a Nebius quota, so I'll check whether the Nebius Scientific AI server reports usage directly.

That Nebius limit is probably an API quota issue on the Scientific AI platform, so let me check the MCP server for any usage or quota-related tools by listing what's available.

No usage or quota tool on the server. I'll check whether the model listings or operation records carry quota fields.

There's no dedicated quota tool, so I should check if list_models returns quota info, or search the chat history for mentions of limits like budget or GPU hours from registration.

Those are per-model input limits, not account quotas. Next I'll check what the sign-up chat says about the allocation and count the jobs we've run.

These are per-model parameters rather than account quota, so I should check actual usage instead—counting operations in the cell-geometry results and checking the registration chat for any stated limit, like Nebius credits, around lines 198-260.

There's no known limit, and the Nebius H100 cluster seems separate with 16 shared GPUs. I should sum the duration across all records to get total compute.

Let me check one operation's details to see if it reveals any quota or usage information.

I can't give you a number, because nothing I can reach tells us what the Nebius limit is or how much of it we've used. What's clear is that our usage so far is tiny.

**What we've used:** 19 jobs on the Nebius Scientific AI Platform. All of them were Cellpose cell-segmentation runs for the Thompson cell-packing tests in `cell-geometry/`. The 8 runs that recorded a duration took about 36 seconds of compute in total, mostly 1.5 to 7 seconds each. Even a small allowance would leave lots of room. Heavy jobs like AlphaFold3 or molecular dynamics would use it up much faster.

**Why I can't measure it:**
- The platform's server has 69 tools, but none reports quota, credits or usage.
- The job records only show progress, not cost. The only "budget" and "limit" fields in the model listings are per-job settings, such as a maximum of 24 candidate designs per protein-design run.
- The sign-up chat said only one person per team could request access and that it was free. It never mentioned an allowance. The H100 cluster is separate: all teams share 16 GPUs, so the risk there is waiting in a queue, not running out.

To get the real number, check the platform console with the sign-in details from the access form, or ask the Nebius staff in the hackathon Discord. If you meant a different limit, like an H100 GPU-hour budget, tell me and I'll look into that.

These fields show progress, not quota limits, so I actually can't determine the real usage from this data since it's so minimal. I should suggest checking the platform console directly or reaching out to Nebius staff on Discord for a clearer answer.

_Tools used: Grep ×5, Read ×2, Shell ×7_

### 2026-10-31 15:07 — Turn 2 (User)

> anything else to use?

**Assistant:**

I'll check which of our claims are molecular enough for the other Nebius models to test.

I'm thinking about what other Nebius tools could fit the project, and want to check the Levin papers' claims about bioelectric signaling and ion channels like HCN2 to see if tools like AlphaFold3, Boltz-2, ESM, or stability prediction models would be relevant — so I'm searching the claims for molecular-related terms to ground the suggestions.

The claims CLI is failing on a malformed TriG draft, so I'll search `claims.json` files directly.

The CLI seems to be choking on a malformed TriG file, likely a draft. I'll just grep claims.json directly instead.

Yes. The best fit is the Levin bioelectricity papers, because they make specific claims about ion channels, gap junctions and drugs that the Nebius models can test. So far we've only used Cellpose. These are the strongest candidates, starting with the cheapest:

- **Bacterial and animal ion channels share one mechanism** (`levin-2019-boundary-14`). Fold a bacterial potassium channel (KcsA) and animal ones (Kv1.5, Kir, HCN2) with ESMFold, then compare their pore and selectivity-filter geometry. It's fast and gives a clear structural yes or no.
- **The HCN2 mutant that doesn't conduct** (`levin-2018-hcn2-12`, `-16`). Run AlphaFold3 or Boltz-2 on the normal and mutant channels, plus the stability-change model (`submit_stab_ddg`) on the mutation. This checks that the mutant still folds and only loses its pore function, which is what the experiment assumes.
- **Octanol blocks gap junctions but hexanol doesn't** (`levin-2015-girardia-11`). Predict a planarian innexin (the invertebrate gap-junction protein) with AlphaFold3, then dock both alcohols with DiffDock or Boltz-2. One caveat: docking scores for two similar small alcohols may not separate them clearly, so this is a weaker test.
- **The tumour result should carry over to mammals** (`levin-2014-tumor-03`, `-05`, `-12`). Compare *Xenopus* and human Kv1.5 and CLIC1 structures. If the channels are conserved, the prediction has a plausible molecular basis.
- **Regeneration should use bioelectric genes across kingdoms** (`levin-2019-boundary-29`). The scVI/scANVI tool (`submit_scvi_scanvi`) can check public single-cell regeneration datasets, such as planarian ones, for enrichment of ion-channel genes. This is the one closest to a real data test.
- **More cell geometry.** The cell-segmentation and tracking tool could take xenobot or anthrobot videos, or Cellpose could cover more species for the Thompson claims we already tested.

Most of this is single structure predictions and docking runs, about 20 to 40 jobs in all, so it should stay well inside any limit. AlphaFold3 and molecular dynamics are the expensive ones, so I'd start with ESMFold and Boltz-2.

Separately, `node mcp/cli.mjs search` currently fails on a malformed TriG file (a bad IRI containing `[`), so I searched `claims.json` directly for this. It needs fixing before the claim-query tools work again.

I'd start with the channel-conservation comparison and the HCN2 mutant check. Both are cheap and each gives a clear answer. Want me to run them?

I'm mapping out concrete proposals: first, examining the HCN2 dominant-negative mutants by comparing WT vs mutant structures with AlphaFold3/Boltz-2 and checking stability changes from the pore mutation, noting it's a limited test since it only confirms folding, not conduction loss. Second, I'm considering docking studies for nicotine binding to HCN2 and nicotinic receptors.

Third, I'm weighing a docking comparison of octanol vs hexanol against planarian innexin structures to test gap junction blockade selectivity, though I suspect affinity scores alone won't cleanly discriminate the two alcohols. Fourth, I'm noting the barium-insensitive planaria claim is a weak candidate for this approach. Fifth, I'm proposing a structural comparison between bacterial channels like KcsA and animal Kv channels to test conservation cheaply via ESM-based tools. Sixth, I'm thinking scVI analysis on planarian regeneration single-cell data could test ion channel expression enrichment well. Seventh, I'm considering comparing Kv1.5/CLIC1 structures across Xenopus and human to test mammalian conservation claims. Eighth, I'm wondering whether Cellpose-based tracking could extend to segmenting xenobot or anthrobot movies.

Beyond that, I should keep the sponsor tooling focused on Nebius rather than drifting into side notes about incomplete Gemini batch runs. On cost, AlphaFold3 is heavier so I'd prefer running ESMFold or Boltz-2 first, and I should offer the user a choice of which to run, keeping things short, while briefly flagging the broken TriG CLI issue.

_Tools used: Shell ×3_

### 2026-10-31 15:10 — Turn 3 (User)

> sure let's do all of them starting with the first 3

**Assistant:**

I'll set up a todo list, then look at how the existing Cellpose pipeline is laid out so the new tests follow the same pattern.

This is a substantial task, so I should plan it out. I'll look at the existing cell-geometry structure for conventions, like segment.py and related files, then set up a new project directory for the molecular/Levin structures work, mirroring those patterns before pulling in the schemas for the various prediction tools.

I also need to figure out the right UniProt sequences — KcsA, human Kv1.5, Kir2.1, and HCN2, being careful about which species Levin's paper actually used (likely mouse Hcn2 rather than human), so I'll need to fetch these via the UniProt REST API. I'll start by building a todo list and reading through the relevant files.

I'll set up a new project directory called `levin-molecular/`, starting with three tests, results JSON, and a README, leaving claim-tests and nanopub generation for later. I also need to pull schemas for esmfold2, stab_ddg, boltz2_predict_native, alphafold3, and diffdock.

The structure tools take a "scientific manifest" artifact rather than a raw sequence, so I need its format. I'll also check which HCN2 mutant the paper used.

I need to figure out the manifest format for ESMFold2's input artifact, and clarify which HCN2 "DN" mutant Levin used—likely the pore selectivity filter GYG→AAA mutation rather than a stability-focused one, since stab_ddg reflects interface binding rather than overall stability.

The native variants don't seem to appear here, so they're probably covered under list_models instead. I should check the esmfold2 entry and the alphafold3 input_artifact_contract for more detail.

I need to check the manifest format for esmfold, so I'll pull the model schema for esmfold2-fast.

`nebius/nebius_mcp.py` existed a few minutes ago and is now gone, as is the HCN2 extraction file. I'll check whether someone else is changing the working tree.

Wait, the file disappeared, and K-2018-hcn2.json too — another agent might be moving things around since git status showed a sentinelayer session with other agents involved. Let me check git status and ls to confirm.

Another agent is reorganising the repo right now: `cell-geometry/` and `nebius/` are being moved under `claim-sources/`. I'll find the new locations and work with them, not against them.

Since another agent is restructuring files into claim-sources/, I need to locate where nebius_mcp.py ended up.

I'm trying to figure out the right location for this new work—maybe something like `claim-sources/levin-molecular/` following the pattern of cell-geometry as a test project. Let me check the modified AGENTS.md for guidance on the current layout conventions before deciding.

I'm trying to figure out where to place my new work given the directory structure is still shifting—claim-tests moved to test-data, cell-geometry sits under claim-sources—so I need to pick a location that won't collide with these in-flux paths.

I want to check the claim-test format conventions by looking at an example result.json and the README in test-data/claim-tests.

I'm setting up three claim-test directories for the Levin papers and planning to pre-register the format first. Since the analysis needs Nebius API calls requiring a key, I'm thinking of building a script that caches outputs to a derived folder, similar to how the cell-geometry case was handled.

Before writing the pipeline, I should read the full claim texts for all three claims plus the hcn2-06 result.json as a reference example, and check the K-2018 extraction to confirm the dominant-negative mutant details.


I'll set up the claim test following repo conventions, creating a dedicated directory under `test-data/claim-tests/levin-papers/` and pre-registering the test before reviewing any data. First, I'll pull the exact claim texts and check what the paper says about the mutant.

I need to be honest about what structural predictions can actually test here. Looking at the sensory channels—Piezo for touch isn't homologous to bacterial mechanosensitive channels like MscS/MscL, and TRP channels involved in taste, temperature, and hearing also lack clear bacterial homologs—so the claim is likely partly false.

Really, the cleanest test would use existing experimental structures and Pfam/InterPro clan data rather than running new folding predictions, since many of these proteins already have AlphaFold DB structures and re-predicting them would be redundant.

Since the user wants Nebius involved, I could run ESMFold there for specific constructs and then compare them locally using TM-align (via the pip-installable tmtools bindings). I'm sketching out a practical set of test proteins: human sensory channels like TRPV1, TRPM8, PIEZO1/2, TMC1, OTOP1, and SCNN1A, plus a Kv control, to compare against bacterial channels like KcsA and NavAb.

For the remaining bacterial channels, I'm adding MscL, MscS, GLIC, and NaK, while skipping MthK. My plan is to fold everything with ESMFold on Nebius, cross-check against AFDB structures, then compute TM-scores between each animal channel and each bacterial channel — normalizing by the shorter bacterial length to test fold containment, with TM ≥ 0.5 as the same-fold threshold, pre-registering that the claim holds only if every sensory modality shows this pattern.

I'm refining the criteria to also require Pfam/InterPro sequence-level evidence alongside structure, pre-registering that all four senses needing a homolog supports the claim, some is mixed, and none refutes it. I expect TRPV1/TRPM8 pore domains to resemble bacterial pore channels like NavAb or KcsA with moderate TM-scores, PIEZO to show no match, and TMC1 to possibly connect through TMEM16's fungal relatives.

I'm questioning whether OTOP and ENaC have any bacterial homologs at all, suspecting the overall result lands on "mixed" rather than fully supporting or refuting. I'm also weighing the quality concerns of running ESMFold on PIEZO2's 2752-residue sequence, since single-sequence folding on large membrane proteins tends to produce low pLDDT scores, and considering whether to cross-check with AlphaFold DB fragments despite the extra effort, ultimately deciding to keep ESMFold as primary and flag low-confidence results.

For the HCN2 question, I'm thinking through how to computationally test whether the dominant-negative GYG→AAA mutant still folds and assembles properly, which would support the claim that it co-assembles with WT without conducting rather than failing to fold entirely.

RMSD comparisons between WT and mutant structures would likely be trivially similar, so a more meaningful test is checking interface binding ddG at the tetramer interfaces to confirm the mutant subunits still assemble. That requires a real PDB structure of an HCN complex, so I'm trying to recall whether a human HCN2 cryo-EM structure exists, or whether I'd need to substitute HCN1 or HCN4 structures instead.

Given this, I'd use AF3 to generate a truncated HCN2 pore-domain tetramer and run stab_ddg comparing WT versus the GYG→AAA mutant at subunit interfaces, along with comparing AF3 confidence scores across WT, fully mutant, and heterotetramer (1 DN + 3 WT) configurations. I recognize this can only test whether the mutant protein still assembles into a tetramer, not actually verify conductance or the claimed phenotype percentage, so the verdict here is limited to assessing whether the premise is structurally consistent rather than confirming the claim itself.

I should pin down the pass/fail criteria — AF3 ipTM scores within 0.05 of WT and interface ddG under 1 kcal/mol for the mutant to support co-assembly — and also check the methods text to confirm whether the paper used mouse or human HCN2 sequences before proceeding to the next test involving planarian innexin docking.

Actually docking octanol/hexanol with DiffDock is a weak approach since it gives no real affinity values, and the real claim about hexanol not altering morphology is experimental, not structural. A better path is comparing against existing alkanol potency literature (Bastiaanse, Weingart & Bukauskas) where hexanol vs octanol IC50 values for gap junction blockade already correlate with lipophilicity.

If I still run docking, I'd need to scope it carefully — pulling planarian innexin sequences (Schmidtea mediterranea or Girardia dorotocephala) from UniProt, predicting structures via AF3/ESMFold, then docking ethanol as a negative control alongside hexanol, heptanol, and octanol, while pre-registering that an inconclusive result is expected if DiffDock can't discriminate.

I also want to check whether openfold3_openbind can predict binding affinity for ligand co-folding, since Boltz-2's native setup here is protein-only. For now, I'll move forward step by step, starting with pulling the manifest schema for esmfold2.


I've confirmed the HCN2 mutant is a GYG→AAA pore mutant that assembles but can't conduct, and that the bacterial-channel claim is specific to senses like touch, taste, temperature, and hearing—so I'll test actual sensory channels rather than just potassium channels. Next, I'll check the input format the folding models expect.

The manifest format isn't documented here, so I should search the tool descriptions for begin_scientific_artifact_upload and submit_scientific_run to see if they mention manifest requirements—let me look for any mentions of "manifest" across the tools.

The manifest format isn't documented in the tool descriptions, so I'll probe it with a small ESMFold job (KcsA, 160 residues) and read the validation errors.

Since the manifest format isn't documented, I'll try guessing one, maybe uploading something with the scientific-manifest media type and see what errors come back to learn the expected schema.

The manifest has to point at uploaded inner files. I'll upload the sequence as FASTA and reference it from the manifest.

I need inner artifacts referencing the uploaded file for ESMFold, probably a FASTA sequence. I'll try uploading the FASTA as an artifact and building a manifest pointing to it with the hash, size, and media type, then iterate based on whatever errors come back.

Progress: entries need a name plus a `semantic_type`. I'll try plausible values.

Seeing that this variant needs a "semantic_type" field, I'll try guessing something like "protein-sequence-fasta/v1" and see if the error message reveals the correct value.

Entries now validate, but the root reference is reported missing. I'll check what `finalize_scientific_artifact_upload` actually returns; it may already hand back a manifest reference.

Entries pass now, but I'm puzzled by the "artifact_id" required error at the root path—the manifest itself seems to be missing that field even though the upload function's return includes it via `_find`. I wonder if the input_manifest reference got dropped somewhere along the way.

Maybe the schema wants each entry to nest its fields under an "artifact" key instead of flattening them. Let me try restructuring entries so each one has name, semantic_type, and an artifact object wrapping the actual data.

The entry must be named `esmfold2-input`. Trying that with the FASTA, and then with a JSON payload if needed.

I'm considering naming this artifact "esmfold2-input" with semantic type "esmfold2-input/v1", trying to decide whether the content should be formatted as FASTA or as JSON containing the sequence.

Rather than keep guessing, I'll collect every `semantic_type` the platform advertises.

Guessing the semantic type blindly isn't efficient, so I should grep for "semantic_type" strings across neb_list.json and neb_models.json to spot patterns, like how alphafold3 uses "alphafold3-fold-input/v1", and check for anything related to esmfold.

I'm comparing AlphaFold3's documented input type against ESMFold's unadvertised one—AF3 uses "alphafold3-fold-input/v1" JSON, offers better quality, and supports multimers which I'll need for the HCN2 tetramer, though its MSA pipeline is slower and costlier. Given our usage is minimal, AF3 with raw input running the MSA search still seems worthwhile for quality.

I'm also weighing Boltz-2, which could work with a single-sequence A3M but would suffer the same low-quality issue as ESMFold without real MSA data. For the boundary-14 set I'm estimating roughly 13 monomer folding jobs, though PIEZO2's huge sequence length will be slow. A better option might be relying on existing experimental PDB structures for most of these channels (TRPV1, TRPM8, PIEZO2, TMC1, OTOP1, ENaC, KcsA, NavAb, MscL, MscS, GLIC), since those are more defensible evidence than a fresh fold, while still using Nebius AF3 for ones lacking full experimental coverage or for consistency checks. I also need to figure out structural alignment tooling, like TM-align or tmtools, for comparing results.

Meanwhile I'm trying different semantic type strings to get ESMFold accepted, since the error doesn't specify what's expected — I'll test a few quick guesses cheaply before committing to a submission.


AlphaFold3's input type is fully documented, but ESMFold's isn't, so I'll batch-test a few more guesses for the latter—rejected requests cost nothing since they aren't admitted.

I've found the esmfold2-input item, a JSON input with sequence and mode fields that was accepted at admission though its content validity is still unconfirmed. I'm waiting on operation c730a3015e774836 before proceeding.


ESMFold expects an `esmfold2-input` entry of type `esmfold2-input-json/v1` with JSON content. I've queued the KcsA test fold and will wait for it to confirm the format is correct before submitting the rest.

The KcsA fold has been queued for over ten minutes, so the platform is busy. While it waits, I'll write the pre-registrations and fetch sequences and reference structures.

This queue is shared and will take a while, so I'll use the wait time to prep other things—pre-registration files, sequences, and structures from PDB—while checking on the operation's status periodically.

The fold is now running. I'll gather inputs: UniProt sequences for the channel panel, the HCN2 species the paper used, and planarian innexins.

I need TM-align for structure comparison, so I'm figuring out how to install tmtools and gemmi in this environment, likely via uv rather than pip given the externally-managed Python setup. Once that's sorted, I'll move on to carefully drafting the pre-registration for levin-2019-boundary.

For this I'm mapping out representative channels across senses in humans — PIEZO2 for touch, TRPV1/TRPM8 for temperature, OTOP1/ENaC/TRPM5 for channel-mediated tastes, and TMC1 for hearing — alongside bacterial channel counterparts like KcsA, NaK, NavAb, MscL, MscS, GLIC, and ELIC. The plan is to compute TM-scores from structural alignments between each animal channel and each bacterial channel, normalized by the bacterial structure length, to test for deep structural homology despite the lack of sequence similarity.

I'm deciding how to source the protein structures, weighing AlphaFold DB's curated MSA-based models as the primary data source against folding sequences myself with ESMFold on Nebius as an independent check, since the two approaches need to agree before I trust a verdict rather than flagging it as mixed.

I realize PIEZO2's length likely gets it split into fragments in the human AFDB proteome, and folding something that large with ESMFold might be too slow or memory-heavy, so I'm considering falling back to an experimental cryo-EM structure for mouse Piezo2 instead. I'm also sketching out controls — a known channel homolog pair as a positive control that should clearly pass the similarity threshold, and a non-channel human protein like myoglobin paired against a bacterial channel as a negative control.

I'm defining the pass/fail/mixed criteria: support requires each of the four sensory modalities to have at least one channel hitting a strong structural similarity score against some bacterial channel, while the positive control passes and the negative control stays low; failure means none do, and mixed means only some do. I'm also running through specific channel comparisons mentally — TRPV1 against a bacterial sodium channel should score well on pore domain alone, while PIEZO2 against a mechanosensitive channel likely won't, and TMC proteins may be hard to match since they belong to a eukaryotic-only superfamily with no clear bacterial counterpart.

ENaC/ASIC also lacks a bacterial homolog, while TRPM5 could carry taste through the broader TRP superfamily's structural similarity. So temperature and taste likely pass, but touch and hearing likely fail, pointing toward an overall mixed verdict rather than a clean support or refute — and I note the claim's own citations (on Nav channel origins and prokaryotic ligand-gated channels) are consistent with this nuanced picture rather than a blanket "same mechanisms" claim.

TM-align comparing a short bacterial channel like KcsA against a huge multi-domain protein like PIEZO2 is computationally feasible, and since pore-forming channels are oligomeric, comparing single subunits still captures the core fold even though the functional pore requires tetramerization. I'm laying out the full set of structures to fold and compare: nine animal channels (PIEZO2, TRPV1, TRPM8, TRPM5, OTOP1, SCNN1A, TMC1, KCNA2 as a positive control, and myoglobin as a negative control) against seven bacterial channels (KcsA, NaK, NavAb, MscL, MscS, GLIC, ELIC), totaling sixteen structure prediction jobs.

For testing whether GYG→AAA HCN2 mutants can still co-assemble with wild-type in a dominant-negative fashion, I'm planning to use AF3 to predict homotetramers of both WT and AAA HCN2 transmembrane cores, plus a mixed 1-AAA/3-WT assembly, comparing ipTM scores and pore filter geometry. Since AF3 tends to be insensitive to point mutations, I'm also considering stability ddG calculations at the subunit interfaces for the glycine and tyrosine substitutions as a way to get a disconfirming signal that structure prediction alone might miss.

Thinking through the logic: if the interface ddG is small, co-assembly shouldn't be impaired and the dominant-negative mechanism holds; if it's large, assembly would be disrupted and the mutant would just be nonfunctional rather than truly dominant-negative. This distinction matters more for claim -16, which depends on the mutant actively suppressing endogenous HCN2 activity through co-assembly, so I think this test targets -16 more directly than -12.

I'll set up one test directory for levin-2018-hcn2-16 but note it also bears on -12, and recall that the GYG→AAA pore mutation is a well-established dominant-negative approach in HCN channels from prior literature (Xue et al. 2002 used a similar construct to suppress HCN1/HCN2 currents), which gives useful context here. Now I need to check which HCN2 species Levin's paper actually used.

For the structural model, I'm leaning toward building an AlphaFold3 tetramer of the HCN2 core (covering roughly S1–S6 and the C-linker, with the GYG motif around residues 424-426 in mouse HCN2) since I'm not confident there's a usable cryo-EM structure available, then converting the mmCIF output to PDB with gemmi for stability/binding ddG calculations. I'm pre-registering a threshold where the total binding ddG for the AAA triple mutant should be ≤1 to count as disruptive.

I'm setting the verdict so that it only tests whether the premise holds (whether the dominant-negative subunit can co-assemble), not the full phenotype, so confidence should stay modest. Then I move on to the next claim about girardia-11, which involves whether hexanol fails to produce altered morphologies experimentally.

For testing whether hexanol inefficiently blocks gap junction channels, I'm weighing computational docking as a weak proxy. I'm considering pre-registering a comparison across octanol, heptanol, hexanol, ethanol as a negative control, and carbenoxolone as a known blocker, docked against a planarian innexin channel model — though building a full octameric channel via AF3 is expensive and monomer docking won't capture the pore properly, and DiffDock's confidence score isn't a real affinity measure anyway.

Since alkanol potency on gap junctions scales with lipophilicity rather than specific binding, I suspect this docking approach will be inconclusive, so I should pre-register it honestly as low-confidence with multiple seeds and poses to check variability, while searching UniProt for the right planarian innexin sequence to use.

For organizing the work, I'll add shared helper functions for AF3/ESMFold/DiffDock submission into a new plugins/nebius/fold.py file rather than editing files other agents might be touching, then check on the background operation.

Since Girardia-specific innexin sequences aren't in UniProt, I'll substitute Schmidtea mediterranea innexins as the closest available planarian relative, flagging this substitution as a caveat since both belong to Tricladida. I'm also noting the mouse HCN2 entry for reference.

Let me check if the KcsA job has finished, and in the meantime set up tools like uv with tmtools and gemmi, verifying the uv installation works.


I'll use the three Schmidtea mediterranea innexins as a stand-in since UniProt has no Girardia entries, noting this as a caveat, then check the local structure-alignment tooling.

ESMFold works: the KcsA fold took 31 seconds of compute after about 12 minutes in the queue. I'll identify which planarian innexin is which and get the mouse HCN2 membrane-domain boundaries.

This works with roughly 30 seconds of compute and a 12-minute queue, downloading output through the manifest artifact which holds entries with artifact ids. I'll write a shared helper that submits an ESMFold job idempotently, waits for it, downloads the cif and confidence files, and records the run in a JSON log, with support for submitting all jobs first then waiting to parallelize them.

Before examining any results I need to write the pre-registrations, per the rules. I already folded KcsA without inspecting the structure, but that's fine — I'll just flag it as a probe run.

Now I'm drafting the three result.json pre-registrations with current timestamps. For the animal panel: touch maps to PIEZO2, hearing to TMC1, temperature to TRPV1 and TRPM8, and taste to OTOP1, SCNN1A, and TRPM5. Controls are KCNA2 as the positive comparison against KcsA and human myoglobin as the negative — though I'm realizing myoglobin's small size makes it a weak negative control since normalizing TM-score by the shorter bacterial chain length biases results toward large animal proteins, so I should pick a larger non-channel protein as a fairer negative control instead.

I'm settling on using two negatives together: myoglobin for a soluble-protein baseline, and human GLUT1 (a 12-TM transporter that isn't a channel) to test whether helical membrane bundles alone can produce misleadingly high scores against bacterial channels. The pre-registered pass criterion becomes: a sense passes only if its best TM-score is at least 0.5 and beats GLUT1's best score against the same bacterial channel by at least 0.1, with any sense whose channels all have mean pLDDT under 50 marked inconclusive. I'm also noting AlphaFold DB cross-checks as an optional caveat rather than a requirement, and now I'm working out the HCN2 test specifics — locating the core transmembrane S1-S6 region in mouse HCN2 (UniProt O88703, 863 residues) to define the right boundaries for comparison.

For HCN2, I'll use UniProt's transmembrane and pore annotations to bound the core region from the first TM minus ten residues to the last TM plus ten, then run three AlphaFold3 jobs: a wild-type homotetramer, a heterotetramer with one mutant subunit among three wild-type, and a fully mutant homotetramer. I'll follow this with stability ddG calculations on the wild-type tetramer PDB, testing the triple mutant on one chain plus individual point mutations, and I'm adding a positive control — mutating the interface residue with the most inter-subunit contacts to arginine — with the pre-registered expectation that this control should produce a ddG of at least 2 kcal/mol to confirm the method's sensitivity.

I'll also note that checking pore geometry (like filter carbonyl ring spacing) between WT and mutant structures isn't something AF3 or ESM can reliably assess, so I'll just report RMSD instead. Finally, I'm laying out clear pre-registered thresholds for the premise: supporting evidence requires WT ipTM ≥0.6, heterotetramer ipTM within 0.1 of WT, mutant binding ddG ≤1.0, and a sensitive control ≥2.0; refuting evidence would be a ddG ≥2.0 or a heterotetramer ipTM drop >0.2; anything else, or an insensitive control, counts as inconclusive.

For the girardia-11 case, I'm weighing whether docking alkanols into a monomeric innexin subunit even makes sense given that the functional channel is an octameric hemichannel (or hexadecamer overall) — docking into a single chain wouldn't capture pore-blocking behavior. I'm considering building a trimmed octamer model to keep the AF3 token budget manageable while still representing the pore region.

I'll run it cheaply: one AF3 octamer job, plus DiffDock across the ligand panel with multiple seeds and poses, pre-registering that this is likely to be inconclusive given DiffDock's poor resolution between short- and long-chain alcohols, but worth doing since it was explicitly requested.

I should also add carbenoxolone as a positive control, since CBX is documented to block innexin/pannexin hemichannels, alongside ethanol as a negative control. Now I need to decide which specific innexin isoform to model among the three candidates.

Smed-inx-11 stands out since it's implicated in neoblast maintenance (Oviedo & Levin), so I'm checking which accession corresponds to inx-11 by pulling up the UniProt entries and their gene names/comments.

A7RDN9 looks like a good target since it's required for regeneration. For HCN2, I'm defining the core domain spanning roughly residues 131-520, covering the subunit assembly region through the C-linker and CNBD that form the tetramer gating ring—about 390 residues per chain, giving 1560 tokens across the tetramer, which should work fine.

I'm noting AF3's raw input mode will run the full MSA pipeline with jackhmmer, which could take over an hour but is acceptable. I'm setting up directory paths for three pre-registration test cases (boundary, HCN2, and Girardia papers), confirming none already exist, and now writing the result.json files for each.


Confirmed A7RDN9 is smedinx-11, the innexin shown in a published study to be required for planarian regeneration—this is the correct target. I'll now write the three pre-registrations before examining any structures, per the claim-test rules.

I'm double-checking the accession numbers for these ion channels - NaK from Bacillus cereus, NavAb from Arcobacter butzleri, ELIC from Erwinia chrysanthemi, and GLIC from Gloeobacter - cross-referencing each against what I recall to confirm they're correct.

The repo's rules say to commit pre-registrations before running anything. Another agent has staged a large reorganisation, so I'll commit only my three files.

Since another agent has staged renames in the index, I need to be careful to commit only the three specified files rather than everything staged. Using git commit with explicit path arguments should restrict the commit to just those paths, which matches the repo's rule to register the commit before anything else.

Pre-registrations are committed (`f0720a27`). Next I'll see how to download results from the KcsA probe so I can write one shared helper for all three tests.

I'm planning a helper module for fold.py that fetches UniProt sequences, submits ESMFold and AF3 jobs with idempotency keys derived from sequence hashes, and collects results by waiting on the operation, then downloading the output manifest and its artifacts.

Downloads work through the output manifest. I'll write the shared helper.

Now I'll create the fold helper file for the nebius plugin.

Now the runner for the channel-ancestry test: fetch the 17 sequences, submit all folds at once, and collect them as they finish.

I'm looking at the fold.py runner script that fetches sequences, submits them to ESMFold, and collects structure outputs into derived/structures. Since generated structure files like the PIEZO2 cif could exceed the 1MB commit limit, I need to check whether they should live in a gitignored data directory based on existing conventions.

I'll put structures under data/ with a .gitignore, and commit run.json records with sha256 hashes instead of the raw files. The KcsA probe used a different service class than the customer batch, so I should refold to keep things consistent rather than reuse the probe output—it's cheap enough. ESMFold's max length is 4096, and PIEZO2 at 2752 residues fits comfortably. Now I'm writing the runner script.

I'm checking that runs.json correctly tracks operation ids after submissions so reruns can detect known entries, which looks correct. Now I'll launch this in the background.

While the upload finishes, I'm putting together the AlphaFold3 JSON input for HCN2, structuring it as a heterotetramer with chains A-D sharing the protein sequence under the alphafold3 dialect format.

I'm working out the HCN2 construct boundaries—residues 131-520 of O88703, locating the GYG selectivity filter motif at position 402-404 to compute its index within the fragment before applying the mutation. For stab_ddg I'll need to probe the workload archive format once AF3 finishes, possibly with a small dummy structure since the manifest's expected input types aren't clear yet. I also need to set up the innexin octamer run using A7RDN9 residues 1-370 across eight chains, then write both runner scripts and kick off submission.


While the channel folds submit, I'll write the AlphaFold3 runner for the three HCN2 tetramer variants (wild type, mixed mutant, all mutant) and the innexin octamer.

I'm planning a two-phase approach for Girardia: run AF3 to predict the octamer structure first, then feed that into DiffDock for docking. I need to write a script that handles phase one now, with phase two as a function that triggers once the receptor structure exists, converting the AF3 CIF output to PDB format via gemmi so it meets DiffDock's size requirements.

I wrote the carbenoxolone SMILES from memory, which isn't reliable, so I'll switch every ligand to PubChem CIDs and fetch the SMILES at docking time.

My carbenoxolone SMILES was likely inaccurate from memory, so I should fetch it from PubChem (CID 636403) instead, along with proper CIDs for the other ligands—ethanol 702, 1-hexanol 8103, 1-heptanol 8129, 1-octanol 957—to ensure accurate structures with proper provenance.

That network error looks transient, maybe related to how the backgrounded subprocess interacts with the sandbox, and b14 seems unusually slow. I should add retry logic for transient URLErrors in the nebius_mcp client.


A network blip killed the HCN2 submitter after its first job, but since submissions are idempotent I can safely re-run it. I'll also add automatic retries to the helper so transient failures don't interrupt future runs.

The upload and download paths aren't fully retried through the RPC layer, but that's acceptable for now. I should relaunch hcn2 in the background using Shell with a zero block time.

While the jobs queue, I'll write the local analysis for the channel test: TM-align every animal channel and control against every bacterial channel, then apply the pre-registered rules.

While I wait, I can write the analysis script for boundary-14's TM-align check: it should read the prediction CIF and confidence JSON, compute mean pLDDT from B-factors, calculate TM-scores between animal/bacterial and control/bacterial pairs, apply the pass/fail criteria, and write all derived numbers into tm_scores.json so result.json only reflects measured values from this analysis.

For the TM-align step itself, I'll use tmtools' tm_align on CA coordinates, treating the bacterial structure as chain2 so the output gives length-normalized TM-score relative to the bacterial reference. I'll use gemmi to parse the CIF file for CA atoms rather than writing my own mmCIF parser, running the script with uv and the tmtools/gemmi dependencies.

The channel submitter hasn't moved past the fourth sequence in several minutes. I'll check whether it's still alive.

The b14 process seems stuck at Q7RTM1 for several minutes, possibly hung on a network error since it's using the old client without retry logic. I should check if it's still alive by looking at terminal 147434.

It's stuck on a network call. I'll restart it with the retrying client; the four jobs already submitted will be re-attached, not duplicated.

This is probably just stuck on a hung HTTP call given the long upload timeout, so I'll kill it and restart with a fresh retry client — since the keys are idempotent, resubmitting should just return the same operations safely, and runs.json only gets written once everything's submitted so that's not at risk.

While those run, I'll work out the stability-predictor (`stab-ddG`) input format the same way, starting from an empty manifest so the error names the required entry.

I should also figure out the stab_ddg manifest format by probing cheaply without submitting. I'll start with an empty manifest to trigger an error message revealing what entry type and semantic name it expects, then guess things like "workload" with semantic "stab-ddg-workload/v1" based on the feedback.

The stability predictor is paused for maintenance on Nebius right now, so the HCN2 energy check will have to wait. I'll retry it later. Checking the folds:

The stab-ddG tool seems paused, so I can't test ddG right now — that means hcn2 would have to be judged on AF3 ipTM alone, leaving the verdict partially inconclusive since the pre-registered plan required ddG. I'm wondering if I should probe DiffDock's availability too, maybe with a dummy invalid call once a receptor exists, to see if it's also down.

All 17 channel folds are submitted and 3 are done; the HCN2 tetramers are queued. The innexin watcher has been silent since 15:51 and is probably hung like the first one, so I'll restart it.

About 30 minutes have elapsed based on the timestamps, with 3 of the tasks done out of 17 total. The old client process seems to have hung since its last log line at 15:51, so I should restart it with the retrying client instead.

While I wait, I'll draft the HCN2 analysis script to parse AF3 summary_confidences for iptm, ptm, and chain_pair_iptm, leaving ddG comparison pending since it's not pre-registered, and I'll compute contact counts from the WT model to select a sensitivity control residue for the stability ddG input, making the analysis tolerant of a missing ddG results file. I'm also checking the AF3 output naming convention for the structure and summary files.


I'll draft the HCN2 analysis now, pulling AlphaFold3's interface confidence and the sensitivity-control residue from the wild-type model, then add in stability results once that service comes back online.

That file-finding approach is a bit hacky; I'll clean it up once I see the actual filenames. For waiting on jobs, instead of sleeping in a shell command, I should check for an AwaitShell tool and look at its schema.

Progress is very slow: after about 70 minutes only 3 of 17 channel folds are done, and none of the AlphaFold3 jobs have finished. I'll check whether they're running or just waiting in the queue.

Only 3 of 17 finished after about 70 minutes, so the queue is moving very slowly. Let me check the status of a few operations to see whether they're still queued or actually running.

That tool error might just be transient on the Cursor side, so I'll try a simpler command instead.

Still no admission for the AF3 jobs after about 70 minutes — the shared hackathon platform seems congested. I should check on the pending ESMFold job too.

Everything's stuck waiting for admission, which makes me suspect a per-team concurrency cap is the culprit. I should check the full operation output for a reason field that might explicitly mention a tenant concurrency limit.


All pending jobs are stuck at ADMISSION_PENDING, which suggests a per-team concurrency cap tied to your original question. I'll check the full operation record for the specific reason.

"admission-unknown" means the submit response may have been lost, so the platform wants a retry with the same idempotency key rather than assuming the op never landed. My runner currently reuses op ids from runs.json instead of actually resubmitting, so I need to fix wait_all to resubmit with the same key when status stays admission_pending/unknown past some threshold.

Simpler approach: since submit is idempotent and returns the same op for a given key, I should just remove the "known op id" shortcut entirely and have runners always call submit (which also re-uploads artifacts idempotently). I'll edit the three runners to always submit rather than reading known ids, then restart them.


Found that jobs are stuck in `admission-unknown` because Nebius never admitted them (submit responses were likely lost to network drops), leaving runners waiting on operation IDs that will never start. I'll fix this by having runners always resubmit with the same idempotency key instead of trusting saved IDs.

I'll also have the wait loop show each job's status, so a stalled admission is visible immediately next time.

I should log the submit response status and have wait_all print per-op status at the first iteration, plus a summary of distinct status counts each loop, to catch cases where "admission_pending" lingers too long without a payload to resubmit with.

I should kill the old runners and restart all three, running them separately in their own background shells rather than sequentially.

The pkill ran at the start before the other processes launched, so the timing should be fine since those start a couple seconds later. I'll wait a few minutes and then check.

Time seems to be jumping around oddly, but the key issue is that resubmission is returning the same op ids and still showing admission_pending — meaning the platform isn't admitting the job at all. I suspect we may have hit some kind of quota or concurrency cap, so I want to check the raw submit response for clues.


Resubmitting gave the same operation IDs, still pending admission — so jobs aren't being admitted at all, not just losing responses. I'll check the raw submit response for the reason, which may relate to the limit you mentioned.

That job was admitted and queued normally. One catch: ESMFold jobs expire two hours after submission, and the queue has been slow. I'll check the status breakdown across all the channel jobs.

Myoglobin appears to already be queued fine with a normal deadline, so the admission_pending ones must be other jobs. I'm noting that ESMFold's graph_deadline of 7200 seconds matters for how the queue handles timing.

If the queue exceeds 2 hours, jobs will expire, which is concerning. I should check current status counts directly once the boundary runner finishes submitting and prints its states.

P02144 also shows admission_pending despite its submit response saying queued, so that status seems to be the normal pre-run state while sitting in the platform's queue, which appears to process roughly one job at a time per tenant. Over the past ~3 hours, 4-5 ESMFold runs completed while PIEZO2 failed, likely due to length or memory limits. I'm now trying to tally which jobs have actually finished so far.

Earlier I found 3 done plus Q8TDI8, suggesting throughput of about one job every 20-40 minutes — at that rate, the remaining 13 ESMFold, 4 AF3, and 15 DiffDock jobs would take many hours, with ESMFold's 2-hour deadline likely causing more expirations. This admission throttle is worth flagging to the user rather than just waiting it out, and I should also check why PIEZO2 specifically failed.


Throughput is the bottleneck—only 4 channel folds have finished in three hours, with everything else stuck in normal queued status, and the PIEZO2 fold failed. Checking why it failed next.

PIEZO2 is running out of memory on the full sequence, so I'm considering folding just the C-terminal pore module plus a few blade segments instead, though that deviates from the pre-registered full-sequence protocol and needs to be documented. Another option is trying a faster, lower-memory ESMFold variant.

Actually, since TM-score is normalized against the bacterial chain anyway, splitting PIEZO2 into two overlapping 1400-residue windows and taking the max TM-score is a reasonable fallback — I'll record this as a deviation and add logic so sequences over 1500 residues get split into overlapping windows with distinct tags, feeding both into the analysis step. Given the current throughput and that it's already 18:43, I should update the user on status now and let the background runners keep going rather than blocking further; I'll also need to handle the possibility that queued ESMFold jobs hit their deadline before running, but that's a problem to solve later. For now, I'll implement the windowing logic and restart the runner.


PIEZO2 is too large for ESMFold's GPU memory, so I'll fold it as two overlapping halves and note this deviation in the pre-registration—normalization against the bacterial chain means this won't bias the results.

The analysis needs to treat the two PIEZO2 halves as one protein, taking the better score of the two.

I need to account for windowed structures, keyed by tag, and handle cases where an accession has multiple windows by taking the appropriate aggregate. I'll build a mapping from accession to the structure tags present, and compute pLDDT per accession using the mean across windows, then update the analysis loading section accordingly.

I'll record the PIEZO2 change in the pre-registration file as a dated deviation, leaving the original criteria untouched.

I should log this deviation in result.json under the deviations list, since the stab_ddg step got paused — let me write that entry now.

Confirming the window split gives residues 1327–2752, which matches what I had. I'll update the user now with status—runners still running in background, nothing to commit yet besides the prereg—and refresh the todo list accordingly.

None of the first three tests has a result yet. They're set up, pre-registered and submitted, but Nebius is barely running our jobs: in about three hours, 4 of our 18 channel folds have finished, and the 4 AlphaFold3 jobs haven't started.

This also answers your earlier question about the Nebius limit. The bottleneck isn't credits; it's how slowly jobs get through the queue. Almost everything sits at `admission_pending` while roughly one job runs at a time. The jobs that did run were fast, 30 seconds to 3 minutes each. ESMFold jobs also expire two hours after submission, so some queued folds may time out and need resubmitting.

**Where each test stands:**
- **Bacterial ion channels (`levin-2019-boundary-14`):** 17 proteins, 18 fold jobs with PIEZO2 split in two. These are the sensory channels for touch, temperature, taste and hearing, 7 bacterial channels, and controls (human Kv1.2 as a positive; myoglobin and the glucose transporter GLUT1 as negatives). Done: TRPV1, TMC1 and MscS. Full-length PIEZO2 ran out of GPU memory, so I'm folding it as two overlapping halves and recorded that as a dated deviation in `result.json`. The structural-alignment analysis is written and runs as soon as the rest finish.
- **HCN2 mutant (`levin-2018-hcn2-16`, also covers `-12`):** This checks whether the GYG→AAA mouse HCN2 used in the paper can still assemble with normal subunits, which is what "dominant-negative" requires. Three AlphaFold3 tetramers are queued. The binding-energy step can't run yet because Nebius has paused that service for maintenance. Without it the verdict stays pending, so I'll retry later.
- **Octanol vs hexanol (`levin-2015-girardia-11`):** The AlphaFold3 model of the planarian innexin channel (smedinx-11) is queued. UniProt has no *Girardia* innexins, so this uses *Schmidtea*. The docking step isn't written yet; it needs that structure first. As stated in the pre-registration, this test may well come out inconclusive.

**What I changed in the repo:**
- Pre-registrations for all three tests, committed on their own as `f0720a27` (before any structure was looked at), in `test-data/claim-tests/levin-papers/<claim>/`.
- A shared helper, `plugins/nebius/fold.py`, for ESMFold, AlphaFold3 and downloads, with retries for the network drops that kept killing the runners.
- Run and analysis scripts for each test. Downloaded structures are gitignored.

Nothing has been signed or published. Another agent is moving folders under `claim-sources/` and `plugins/` at the same time; I worked within the new layout and committed only my own files.

The runners keep going in the background. Want me to check back and run the analyses as results land? I'd hold off on the other three tests (Kv1.5/CLIC1, the single-cell regeneration data, more cell geometry) until this queue clears.

I should address what's actually limiting things here: queue throughput. I'll keep the answer focused and brief.

_Tools used: AwaitShell ×3, GetDynamicTools ×2, Read ×4, Shell ×56, StrReplace ×14, TodoWrite ×2, Write ×13_
